| 浅析跨国制药巨头与国内制药企业之间的专利纠纷 |
| |
| 引用本文： | 刘娟,董丽,王菲,吴慧芳,安文华.浅析跨国制药巨头与国内制药企业之间的专利纠纷[J].中国药房,2011(29):2689-2691. |
| |
| 作者姓名： | 刘娟 董丽 王菲 吴慧芳 安文华 |
| |
| 作者单位： | 沈阳药科大学工商管理学院;江苏吉贝尔药业有限公司;北京东方比特科技有限公司; |
| |
| 摘 要： | 目的:为国内制药企业应对或减少专利纠纷提供参考。方法:从跨国制药巨头与国内制药企业之间的专利纠纷案入手,深入分析案件背后的原因,进而提出对策。结果与结论:跨国制药巨头与国内制药企业之间存在专利纠纷的原因主要包括国内制药企业自身存在的不足、跨国制药巨头的专利战略日益升级以及专利本身的复杂性。国内制药企业应针对纠纷原因,从提高创新药物研发能力、增强专利意识以及主动利用专利本身的复杂性等方面入手,沉着应对与跨国制药巨头之间的专利纠纷,进而有效地回击跨国制药巨头发动的专利战。
|
| 关 键 词： | 跨国制药巨头 国内制药企业 专利纠纷 |
Analysis of Patent Disputes between Multinational Pharmaceutical Magnate and Domestic Pharmaceutical Enterprises |
| |
| LIU Juan,DONG Li WANG Fei WU Hui-fang,AN Wen-hua.Analysis of Patent Disputes between Multinational Pharmaceutical Magnate and Domestic Pharmaceutical Enterprises[J].China Pharmacy,2011(29):2689-2691. |
| |
| Authors: | LIU Juan DONG Li WANG Fei WU Hui-fang AN Wen-hua |
| |
| Institution: | LIU Juan,DONG Li(School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China) WANG Fei(Jiangsu Jibeier Pharmaceutical Co.,Ltd.,Zhenjiang 212000,China) WU Hui-fang,AN Wen-hua(Beijing Eastern Bit Technology Co.,Beijing 100037,China) |
| |
| Abstract: | OBJECTIVE:To provide reference for domestic pharmaceutical companies to counter or reduce patent disputes. METHODS:Starting from patent dispute cases between multinational pharmaceutical magnate and domestic pharmaceutical enterprises,the reasons behind the cases were analyzed deeply to put forward countermeasures. RESULTS & CONCLUSIONS:The reasons for patent disputes between multinational pharmaceutical magnate and domestic pharmaceutical enterprises mainly include the shortcomings of domestic pharmaceutic... |
| |
| Keywords: | Multinational pharmaceutical magnate Domestic pharmaceutical enterprises Patent disputes |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
